Multiple Sclerosis News and Research RSS Feed - Multiple Sclerosis News and Research

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

In MS, the protein coating called myelin, which protects nerves and helps electrical signals travel from the brain to the rest of the body, is damaged. The immune system, which usually fights infection, mistakes myelin for a foreign body and attacks it, stripping it from around the nerves. Exactly what causes this abnormal immune response is unclear, but research suggests a combination of both genetic and environmental factors.

The damaged myelin disrupts the transfer of nerve signals which may slow down, become distorted or stop altogether. This can cause severe symptoms ranging from vision loss through to muscle stiffness, loss of control over muscle movement, difficulties with balance and poor co-ordination.

Around 100,000 people in the UK have MS and it affects about three times as many women as men. The usual age at which diagnosis occurs is around 30, however, symptoms often first develop between the ages of 15 and 45.

Currently, there is no cure for MS but therapeutic approaches such as physiotherapy and steroid injections are used to manage the condition and ease symptoms.
Bariatric surgery may be risk factor for condition that causes severe headaches

Bariatric surgery may be risk factor for condition that causes severe headaches

Bariatric surgery may be a risk factor for a condition that causes severe headaches, according to a study published in the October 22, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology. [More]
YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist -- PAS-YNSα8 -- which has been jointly developed by scientists at the Weizmann Institute and XL-protein. [More]
Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

But on Wednesday in Charlotte, Kay Hagan stood without hesitation next to Janet Colm, chief executive of the Planned Parenthood Action Fund of Central North Carolina, and proudly bashed her opponent, Thom Tillis, for reducing women's rights on abortion and birth control. [More]
Issues on coverage: Steep Rx costs; federal plan eliminates 'transgender exclusion'

Issues on coverage: Steep Rx costs; federal plan eliminates 'transgender exclusion'

Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers. [More]
Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

Research roundup: Older consumers' spending on health care; hospital leaders' views of reporting quality

In 2011, households with at least one member between ages 50 and 64 spent 8 percent of their total budget on health items, compared with 19 percent for those age 85 or over. [More]
Four UCLA researchers receive NIH Director's New Innovator Award

Four UCLA researchers receive NIH Director's New Innovator Award

Four scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received a National Institutes of Health Director's New Innovator Award that will forward revolutionary stem cell and neuro-science in medicine. [More]
Scientists say fundamental theory about how thymus educates immune police appears to be wrong

Scientists say fundamental theory about how thymus educates immune police appears to be wrong

A fundamental theory about how our thymus educates our immune police appears to be wrong, scientists say. [More]
Women with healthy diet and lifestyle less likely to have stroke

Women with healthy diet and lifestyle less likely to have stroke

Women with a healthy diet and lifestyle may be less likely to have a stroke by more than half, according to a study published in the October 8, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
OMRF scientist selected to receive EMD Serono's Grant for Multiple Sclerosis Innovation

OMRF scientist selected to receive EMD Serono's Grant for Multiple Sclerosis Innovation

An Oklahoma Medical Research Foundation scientist has been selected to receive one of only five Grants for Multiple Sclerosis Innovation awarded this year by the pharmaceutical company EMD Serono. [More]
Researchers find potential new way to better control immune-mediated diseases

Researchers find potential new way to better control immune-mediated diseases

Researchers at University of California, San Diego School of Medicine have discovered that T-cells - a type of white blood cell that learns to recognize and attack microbial pathogens - are activated by a pain receptor. [More]
Kessler Foundation, NJHF partner to advance biomedical research

Kessler Foundation, NJHF partner to advance biomedical research

The signing of a formal affiliation agreement that allows Kessler Foundation and New Jersey Health Foundation to work together to advance biomedical research, education and patient care programs has been announced by Rodger DeRose, president and chief executive officer of Kessler Foundation and James M. Golubieski, president of New Jersey Health Foundation. [More]
Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Diet may influence susceptibility to autoinflammatory bone disease in at-risk individuals

Diet-induced changes in the gut's bacterial ecosystem can alter susceptibility to an autoinflammatory bone disease by modifying the immune response, St. Jude Children's Research Hospital scientists reported. The findings appeared September 28 as an advanced online publication of the scientific journal Nature. [More]
Placenta-derived cells are safe for MS patients

Placenta-derived cells are safe for MS patients

Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. [More]
MS patients can benefit from strength training and fitness exercises

MS patients can benefit from strength training and fitness exercises

A study developed at the Miguel Hernández University of Elche (Spain) has preliminarily concluded that people with multiple sclerosis may reduce perceived fatigue and increase mobility through a series of combined strength training and fitness exercises. [More]
Early exposure to marijuana can lead to immune-related diseases in adulthood

Early exposure to marijuana can lead to immune-related diseases in adulthood

When it comes to using marijuana, new research, involving mice and published in the October 2014 issue of the Journal of Leukocyte Biology, suggests that just because you can do it, doesn't mean that you should. That's because a team of Italian scientists have found that using marijuana in adolescence may do serious long-term damage to the immune system. [More]
AAN releases new position statement on opioids for chronic non-cancer pain

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain. [More]
Diplomat's clinical technology manager honored as finalist in 2014 Next-Generation Pharmacist awards

Diplomat's clinical technology manager honored as finalist in 2014 Next-Generation Pharmacist awards

Diplomat, the nation's largest independent specialty pharmacy, is proud to announce that clinical technology manager Mike Crowe, PharmD, MBA, CSP, FMPA, was honored as a finalist in the 2014 Next-Generation Pharmacist awards. [More]
Dr. Nancy Chiaravalloti of Kessler Foundation receives Alumni Achievement in Science award

Dr. Nancy Chiaravalloti of Kessler Foundation receives Alumni Achievement in Science award

Nancy (Donofrio) Chiaravalloti, PhD, of Kessler Foundation received the Alumni Achievement in Science award from her alma mater, Muhlenberg College at the Alumni Association luncheon on September 13th. [More]
EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono declares winners of first Grant for Oncology Innovation

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, today announced the winners of the first Grant for Oncology Innovation (GOI), who will receive grants totaling $1.3 million. [More]
People with memory loss more likely to develop dementia later, study finds

People with memory loss more likely to develop dementia later, study finds

New research suggests that people without dementia who begin reporting memory issues may be more likely to develop dementia later, even if they have no clinical signs of the disease. [More]